Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$176
-$29,442 QoQ
Shares Held
52
-99.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. LSTA ranks #386 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in LSTA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $176 52
2026-03-31 $29,618 5,912
2025-12-31 $10,996 5,913
2025-09-30 $15,489 5,912
2025-06-30 $17,144 5,912
2025-03-31 $13,892 5,912
2024-12-31 $154 52
2024-09-30 $156 52
2024-06-30 $180 52
2024-03-31 $161 52
2023-12-31 $141 52
2023-09-30 $110 52
2023-06-30 $192 52
2023-03-31 $168 52
2022-12-31 $130 52
2022-09-30 $64 14